Shares of Healthequity Inc (NASDAQ:HQY) have received a consensus rating of “Buy” from the seventeen analysts that are currently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $76.00.
A number of equities research analysts recently weighed in on HQY shares. SunTrust Banks dropped their price target on Healthequity to $80.00 and set a “buy” rating for the company in a report on Monday, September 9th. Oppenheimer decreased their target price on Healthequity from $98.00 to $76.00 and set an “outperform” rating on the stock in a report on Wednesday, September 4th. Deutsche Bank assumed coverage on Healthequity in a research note on Thursday, September 12th. They issued a “buy” rating and a $74.00 target price for the company. TheStreet cut Healthequity from a “b” rating to a “c+” rating in a report on Tuesday, September 3rd. Finally, Raymond James upgraded shares of Healthequity from an “outperform” rating to a “strong-buy” rating and reduced their price target for the stock from $90.00 to $80.00 in a research report on Monday, September 9th.
Healthequity stock traded up $2.03 during trading hours on Friday, hitting $63.27. 274,078 shares of the stock were exchanged, compared to its average volume of 463,222. The company has a debt-to-equity ratio of 0.04, a quick ratio of 22.98 and a current ratio of 22.98. The stock has a market capitalization of $4.44 billion, a P/E ratio of 66.65, a P/E/G ratio of 2.87 and a beta of 1.47. Healthequity has a 12 month low of $50.29 and a 12 month high of $91.19. The business’s 50-day moving average is $59.78 and its two-hundred day moving average is $64.21.
Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, December 3rd. The company reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.33. The company had revenue of $157.12 million during the quarter, compared to analysts’ expectations of $152.38 million. Healthequity had a net margin of 28.13% and a return on equity of 11.77%. Healthequity’s quarterly revenue was up 122.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.25 earnings per share. On average, equities analysts predict that Healthequity will post 0.87 earnings per share for the current fiscal year.
In related news, CFO Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $61.61, for a total value of $246,440.00. Following the transaction, the chief financial officer now owns 46,000 shares in the company, valued at $2,834,060. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders have sold 12,000 shares of company stock worth $715,600 in the last ninety days. 3.70% of the stock is currently owned by insiders.
A number of hedge funds have recently made changes to their positions in the business. Meeder Asset Management Inc. bought a new position in shares of Healthequity in the 2nd quarter worth $25,000. BerganKDV Wealth Management LLC bought a new position in Healthequity during the second quarter worth about $26,000. FTB Advisors Inc. bought a new position in Healthequity during the second quarter worth about $27,000. Griffin Asset Management Inc. acquired a new position in shares of Healthequity during the 2nd quarter worth about $29,000. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. acquired a new position in shares of Healthequity during the 2nd quarter worth about $39,000. 95.84% of the stock is currently owned by hedge funds and other institutional investors.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: What is a Buy-Side Analyst?
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.